Navigation Links
FreeStyle Freedom Blood Glucose Monitoring System

ProductsFreeStyle Freedom Blood Glucose Monitoring System
Company Abbott Diabetes Care
Item FreeStyle Freedom Blood Glucose Monitoring System
Features 
  • Smallest sample size (0.3 microliter) delivers Virtually Pain-Free Testing
  • Fast, 5-second average test time
  • 4 programmable alarms remind patients when to test
  • 60-second sample reapplication time and fill-trigger prevent test from starting without an adequate blood sample
Description The FreeStyle Freedom Blood Glucose Monitoring System has the largest reading of any leading meter, so it's really easy to see and hold. FreeStyle Freedom delivers Virtually Pain-Free Testing by taking the smallest sample of blood. And it's fastyou'll get results in an average of 5 seconds. With 4 programmable alarms, you'll know when it's time for another reading.
Info Abbott Diabetes Care
Customer Service: (888) 522-5226
Web site: http://abbottdiabetescare.com

Related medicine products :

1. FreeStyle CoPilot™
2. FreeStyle Portable Oxygen Concentrator
3. Freedom EVO Clinical
4. Freedom EVO 150
5. Freedom EVO 200
6. Freedom EVO 100
7. FreedomAire Surgical Helmet System
8. Freedom® CMC ThumbFit™
9. Freedom Clear® SS External Catheters
10. Freedom Clear® LS External Catheters
11. Freedom® Clear Advantage® External Catheter
CX41 Microscopes
CX31 Microscopes
...designed from the ground-up with ergonomic concern...justable observation tube on the market. Optional ...every user can adjust the microscope to suit their...s the operator maintain an upright, comfortable po...
Eclipse TS100F
Medicine Products:
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allreci...ord-high Thanksgiving traffic numbers, with more t...ng, providing a clear picture of what was served o...e Thanksgiving meal in 2009 weighed in at 2,225 ca... year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...an,orthopedic implants company focused on silicon ... Ashok Khandkar, Ph.D., Chief Executive,Officer, a...f Financial,Officer, are scheduled to present at t...Khandkar and Mr. Gallacher will provide a general ...
...A preparation with no,detectable large RNA and fur... developing area of RNAi, ST....s pleased to introduce mirPremier(TM) microRNA Iso...,purifying and enriching miRNA along with other sm...
...ed those with Lou Gehrig,s disease , , THU...ntibiotic minocycline against amyotrophic lateral ...ed because patients taking the drug had a signific...s such as multiple sclerosis, said a report publis...
...aloon will,host a tribute to the late songwriter W...PM to raise research money and awareness for Mesot...much loved and respected troubadour.,Tickets for t...ds from the show will go to The Mesothelioma Appli...
...anxiety from stressful life situations may be more...ast the first six months after the event, accordin...the journal SLEEP. , The study, authored by Jussi...urbed sleep and 2,572 with disturbed sleep, all of...
...,unveil the successor to its unique Xcelodose syst...and vials at the American Association of,Pharmaceu...o (November 11th,-15th, 2007). The new Xcelodose ...nded software functionality. These enhancements w...
Other Medicine News:Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 2Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 3Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma 2Health News:Anxiety linked to sleep disturbances 2Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3